BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 18680095)

  • 21. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery.
    Di W; Ren X; Zhao H; Shirahata N; Sakka Y; Qin W
    Biomaterials; 2011 Oct; 32(29):7226-33. PubMed ID: 21745687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing transversal relaxation for magnetite nanoparticles in MR imaging using Gd³+- chelated mesoporous silica shells.
    Huang CC; Tsai CY; Sheu HS; Chuang KY; Su CH; Jeng US; Cheng FY; Su CH; Lei HY; Yeh CS
    ACS Nano; 2011 May; 5(5):3905-16. PubMed ID: 21513334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.
    Shen J; Zhong XM; Duan XH; Cheng LN; Hong GB; Bi XB; Liu Y
    Acad Radiol; 2009 Sep; 16(9):1142-54. PubMed ID: 19660710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
    Zhao Y; Trewyn BG; Slowing II; Lin VS
    J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
    Cheon J; Lee JH
    Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gd-Al co-doped mesoporous silica nanoparticles loaded with Ru(bpy)₃²⁺ as a dual-modality probe for fluorescence and magnetic resonance imaging.
    Zhang D; Gao A; Xu Y; Yin XB; He XW; Zhang YK
    Analyst; 2014 Sep; 139(18):4613-9. PubMed ID: 25046328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging.
    Anderson SA; Lee KK; Frank JA
    Invest Radiol; 2006 Mar; 41(3):332-8. PubMed ID: 16481917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Labeling transplanted mice islet with polyvinylpyrrolidone coated superparamagnetic iron oxide nanoparticles for in vivo detection by magnetic resonance imaging.
    Huang H; Xie Q; Kang M; Zhang B; Zhang H; Chen J; Zhai C; Yang D; Jiang B; Wu Y
    Nanotechnology; 2009 Sep; 20(36):365101. PubMed ID: 19687538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging.
    Vuu K; Xie J; McDonald MA; Bernardo M; Hunter F; Zhang Y; Li K; Bednarski M; Guccione S
    Bioconjug Chem; 2005; 16(4):995-9. PubMed ID: 16029042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
    Lu F; Wu SH; Hung Y; Mou CY
    Small; 2009 Jun; 5(12):1408-13. PubMed ID: 19296554
    [No Abstract]   [Full Text] [Related]  

  • 32. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
    Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
    Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
    Carniato F; Tei L; Cossi M; Marchese L; Botta M
    Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere.
    Vivero-Escoto JL; Slowing II; Wu CW; Lin VS
    J Am Chem Soc; 2009 Mar; 131(10):3462-3. PubMed ID: 19275256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemically reducible lipid bilayer coated mesoporous silica nanoparticles demonstrating controlled release and HeLa and normal mouse liver cell biocompatibility and cellular internalization.
    Roggers RA; Lin VS; Trewyn BG
    Mol Pharm; 2012 Sep; 9(9):2770-7. PubMed ID: 22738645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.
    Park IY; Kim IY; Yoo MK; Choi YJ; Cho MH; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):280-7. PubMed ID: 18490119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
    Chan MH; Lin HM
    Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.